Horan Capital Advisors LLC. bought a new position in Aflac Incorporated (NYSE:AFL) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,028 shares of the financial services provider’s stock, valued at approximately $235,000.
A number of other hedge funds have also recently added to or reduced their stakes in the company. CWM LLC boosted its position in shares of Aflac by 2.1% in the second quarter. CWM LLC now owns 1,430 shares of the financial services provider’s stock worth $111,000 after buying an additional 30 shares during the period. Washington Trust Bank boosted its position in shares of Aflac by 0.9% in the second quarter. Washington Trust Bank now owns 1,704 shares of the financial services provider’s stock worth $132,000 after buying an additional 16 shares during the period. Harfst & Associates Inc. bought a new position in shares of Aflac during the first quarter worth approximately $128,000. ClariVest Asset Management LLC bought a new position in shares of Aflac during the second quarter worth approximately $150,000. Finally, Sit Investment Associates Inc. boosted its position in shares of Aflac by 1.8% in the second quarter. Sit Investment Associates Inc. now owns 2,137 shares of the financial services provider’s stock worth $166,000 after buying an additional 37 shares during the period. Institutional investors own 64.59% of the company’s stock.
Aflac Incorporated (AFL) opened at 79.71 on Tuesday. The stock’s 50 day moving average price is $79.19 and its 200 day moving average price is $75.12. Aflac Incorporated has a 1-year low of $66.50 and a 1-year high of $81.89. The stock has a market capitalization of $31.50 billion, a PE ratio of 12.05 and a beta of 0.99.
Aflac (NYSE:AFL) last released its quarterly earnings data on Thursday, July 27th. The financial services provider reported $1.83 EPS for the quarter, topping the consensus estimate of $1.63 by $0.20. The company had revenue of $5.43 billion for the quarter, compared to the consensus estimate of $5.48 billion. Aflac had a return on equity of 13.09% and a net margin of 11.98%. Aflac’s quarterly revenue was down .2% on a year-over-year basis. During the same period last year, the business posted $1.65 EPS. On average, equities research analysts predict that Aflac Incorporated will post $6.69 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 1st. Shareholders of record on Wednesday, August 23rd will be issued a dividend of $0.43 per share. The ex-dividend date is Monday, August 21st. This represents a $1.72 annualized dividend and a yield of 2.16%. Aflac’s payout ratio is currently 25.94%.
Aflac declared that its board has approved a stock repurchase program on Tuesday, August 8th that permits the company to buyback 40,000,000 outstanding shares. This buyback authorization permits the financial services provider to purchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s leadership believes its stock is undervalued.
WARNING: This story was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://sportsperspectives.com/2017/08/22/horan-capital-advisors-llc-invests-235000-in-aflac-incorporated-afl.html.
A number of brokerages have commented on AFL. Zacks Investment Research raised Aflac from a “hold” rating to a “buy” rating and set a $84.00 price target on the stock in a research note on Friday, June 2nd. Royal Bank Of Canada reaffirmed an “underperform” rating and issued a $66.00 price target (up from $62.00) on shares of Aflac in a research note on Monday, May 1st. FBR & Co reaffirmed a “market perform” rating and issued a $80.00 price target (up from $68.00) on shares of Aflac in a research note on Wednesday, July 12th. Barclays PLC lifted their price target on Aflac from $71.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, July 3rd. Finally, BidaskClub cut Aflac from a “hold” rating to a “sell” rating in a research note on Wednesday, July 19th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the stock. Aflac presently has a consensus rating of “Hold” and a consensus target price of $76.50.
In other Aflac news, President Kriss Cloninger III sold 2,500 shares of the firm’s stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $77.72, for a total transaction of $194,300.00. Following the transaction, the president now directly owns 241,646 shares in the company, valued at approximately $18,780,727.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Karole Lloyd acquired 1,000 shares of Aflac stock in a transaction on Monday, June 12th. The shares were purchased at an average price of $77.01 per share, for a total transaction of $77,010.00. Following the completion of the acquisition, the director now directly owns 7,253 shares in the company, valued at $558,553.53. The disclosure for this purchase can be found here. Insiders have sold a total of 240,203 shares of company stock worth $18,612,224 over the last 90 days. 3.00% of the stock is currently owned by company insiders.
Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company’s insurance business consists of two segments: Aflac Japan and Aflac U.S.
Receive News & Ratings for Aflac Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.